Taken together, our data show that beyond the current I(f), Ivabradine may induce cardiac protection against myocardial infarction by preventing the secretion of CyPA and binding to LG-EMMPRIN to prevent ECM-degrading MMP-9 expression in response to IR. This evidence concerns the gene MMP9 and myocardial infarction.